Sigrid Therapeutics’ SIGRID Stabiliser Expands to Physical Stores After Online Success
Stockholm, August 27, 2025. Following an exceptionally successful online launch earlier this year, Sigrid Therapeutics and Kronans Apotek are now set to take the next step: SIGRID Stabiliser will be available on store shelves across the country in the fall of 2025.
The launch of SIGRID Stabiliser on Sigrid’s own e-commerce platform resulted in the product selling out within months. Now, Sweden’s largest pharmacy chain, Kronans Apotek, reports that since the product was launched in their e-commerce in February, demand has continued to exceed all expectations.
The product has sold out on several occasions, and during promotional periods, it has been the most requested product in three segments: Trend, Self-Care, and Campaign. The interest has been so great that customers have actively searched for it in physical stores – which in turn has led to pharmacy staff requesting to stock the product in their physical assortment.
This strong consumer response has led Kronans Apotek to prepare an extensive launch in up to 100 physical pharmacies from the fall of 2025, with a particular focus on stores in all major Swedish cities. SIGRID Stabiliser will also continue to be available via Kronans Apotek’s own e-commerce platform, to ensure that all customers – regardless of where they live in the country – can easily order and access the product.
“We are incredibly proud to see SIGRID Stabiliser helping people take control of their health – without prescriptions, side effects, or sacrifices,” says Kasper Wickzén, Chief Commercial Officer at Sigrid Therapeutics. “Our brand is about living life to the fullest. SIGRID Stabiliser fits easily into your daily routine – no dietary changes are needed. By optimizing how your body digests food, you feel more energetic and in control throughout the day.”
Jörgen Bitzekis, E-commerce Director at Kronans Apotek, adds:
“SIGRID Stabiliser has been an immediate success with our online customers – a very successful launch. We quickly saw that demand was far beyond expectations – especially during campaigns – and we are pleased to be able to respond to that interest with broader availability in stores this fall.”
A Cutting-Edge Technology – With Strong Results
SIGRID Stabiliser is based on the award-winning and patented SiPore® technology, initially developed at Professor Tore Bengtsson’s laboratory at Stockholm University. SiPore® acts locally in the gut by slowing down the breakdown of carbohydrates, which leads to more stable blood sugar levels, reduced cravings, and a better feeling of satiety – all without affecting the rest of the body.
Clinical studies and user surveys show strong results:
- 93% experience increased satiety
- 89% report reduced cravings
- 92% feel less bloating
About SIGRID Stabiliser and SiPore®
SIGRID Stabiliser is based on SiPore®, a patented food-grade mineral developed over more than 15 years of research in Sweden. It acts locally in the gut by capturing digestive enzymes, slowing down the breakdown of carbohydrates and fats, and reducing the absorption of glucose – which supports stable energy, appetite control, and fewer blood sugar fluctuations after meals. The SiPore® technology has been studied extensively in 6 clinical studies and published in 8 peer-reviewed scientific articles.
Partner With Us
Driven by solid clinical evidence, strong customer loyalty, and accelerating commercial success, we have now initiated active dialogues with strategic partners and investors to strengthen our global presence.
About Kronans Apotek
Kronans Apotek is Sweden’s largest pharmacy chain with approximately 500 pharmacies, including 45 franchise pharmacies, as well as an e-commerce platform offering over 20,000 products. With a strong presence from Skåne to Lapland and a wide range of health and pharmaceutical products, Kronans Apotek plays a leading role in offering its customers solutions for better health.
Enjoyed this post by Thibault Helle? Subscribe for more insights and updates straight from the source.